• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Coronary artery revascularization: past, present, future: part II--newer technologies.冠状动脉血运重建：过去、现在与未来：第二部分——新技术
Clin Cardiol. 2006 Aug;29(8):341-4. doi: 10.1002/clc.4960290805.
2
Coronary arterial revascularization: past, present, future: part I--historical trials.冠状动脉血运重建：过去、现在与未来：第一部分——历史试验
Clin Cardiol. 2006 Jul;29(7):290-4. doi: 10.1002/clc.4960290704.
3
Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization.糖尿病患者的冠心病：第二部分：冠状动脉血运重建的最新进展
J Am Coll Cardiol. 2007 Feb 13;49(6):643-56. doi: 10.1016/j.jacc.2006.09.045. Epub 2007 Jan 26.
4
Hybrid coronary revascularization in the era of drug-eluting stents.药物洗脱支架时代的杂交冠状动脉血运重建术。
Ann Thorac Surg. 2004 Nov;78(5):1861-7. doi: 10.1016/j.athoracsur.2004.07.024.
5
What will surgical coronary revascularization look like in 25 years?25 年后的外科冠状动脉血运重建术会是什么样子？
Curr Opin Cardiol. 2019 Nov;34(6):637-644. doi: 10.1097/HCO.0000000000000680.
6
Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.经皮冠状动脉介入治疗和冠状动脉旁路移植术的当前临床疗效。
Ann Thorac Surg. 2008 Aug;86(2):496-503; discussion 503. doi: 10.1016/j.athoracsur.2008.03.060.
7
[Coronary angioplasty in elderly patients].[老年患者的冠状动脉血管成形术]
Ital Heart J Suppl. 2002 Jan;3(1):1-8.
8
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.既往冠状动脉旁路移植术后患者应用新一代药物洗脱支架的长期预后。
J Am Heart Assoc. 2018 Jan 30;7(3):e007212. doi: 10.1161/JAHA.117.007212.
9
[Clinical decision making in left main coronary artery disease revascularization: the past, present and future].[左主干冠状动脉疾病血运重建的临床决策：过去、现在与未来]
Recenti Prog Med. 2012 Mar;103(3):119-27. doi: 10.1701/1046.11403.
10
Coronary artery surgery: conventional coronary artery bypass grafting versus off-pump coronary artery bypass grafting.冠状动脉手术：传统冠状动脉旁路移植术与非体外循环冠状动脉旁路移植术
Curr Opin Cardiol. 2005 Nov;20(6):509-16. doi: 10.1097/01.hco.0000179817.88200.60.

本文引用的文献

1
Neurocognitive complications after coronary artery bypass surgery.
Ann Neurol. 2005 May;57(5):615-21. doi: 10.1002/ana.20481.
2
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH).药物洗脱支架植入术经皮治疗左主干冠状动脉疾病的短期和长期临床结果：来自鹿特丹心脏病医院登记处（RESEARCH和T-SEARCH）对雷帕霉素洗脱支架和紫杉醇洗脱支架的评估见解。
Circulation. 2005 Mar 22;111(11):1383-9. doi: 10.1161/01.CIR.0000158486.20865.8B.
3
Early and mid-term results of drug-eluting stent implantation in unprotected left main.药物洗脱支架植入术治疗无保护左主干病变的早期和中期结果
Circulation. 2005 Feb 15;111(6):791-5. doi: 10.1161/01.CIR.0000155256.88940.F8. Epub 2005 Feb 7.
4
Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.西罗莫司洗脱支架植入术治疗无保护左主干冠状动脉狭窄：与裸金属支架植入术的比较。
J Am Coll Cardiol. 2005 Feb 1;45(3):351-6. doi: 10.1016/j.jacc.2004.10.039.
5
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).美国心脏病学会/美国心脏协会冠状动脉搭桥手术2004年指南更新：美国心脏病学会/美国心脏协会实践指南工作组（更新1999年冠状动脉搭桥手术指南委员会）报告
Circulation. 2004 Oct 5;110(14):e340-437.
6
Rapamycin-eluting stents for the treatment of unprotected left main coronary disease.
Am Heart J. 2004 Sep;148(3):481-5. doi: 10.1016/j.ahj.2004.03.011.
7
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.药物洗脱支架随机临床试验的分层贝叶斯荟萃分析。
Lancet. 2004;364(9434):583-91. doi: 10.1016/S0140-6736(04)16850-5.
8
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.西罗莫司洗脱支架治疗复杂冠状动脉狭窄的成本效益：来自西罗莫司洗脱球囊扩张支架治疗初发原发性冠状动脉病变患者（SIRIUS）试验的结果。
Circulation. 2004 Aug 3;110(5):508-14. doi: 10.1161/01.CIR.0000136821.99814.43. Epub 2004 Jul 19.
9
A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery.一项关于微创直接冠状动脉旁路移植术与经皮冠状动脉腔内血管成形术加支架置入术治疗左前降支冠状动脉近端狭窄的多中心随机对照试验。
Health Technol Assess. 2004 Apr;8(16):1-43. doi: 10.3310/hta8160.
10
Off-pump coronary artery bypass surgery: fundamentals for the clinical cardiologist.非体外循环冠状动脉搭桥手术：临床心脏病专家基础指南
Circulation. 2004 Mar 16;109(10):1206-11. doi: 10.1161/01.CIR.0000120292.65143.F5.

冠状动脉血运重建：过去、现在与未来：第二部分——新技术

Coronary artery revascularization: past, present, future: part II--newer technologies.

作者信息

Gupta Anuj, Burke James, Bove Alfred

机构信息

Division of Cardiology, Department of Medicine Temple University Hospital Philadelphia, PA 19140, USA.

出版信息

Clin Cardiol. 2006 Aug;29(8):341-4. doi: 10.1002/clc.4960290805.

DOI:10.1002/clc.4960290805
PMID:16933574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6653836/
Abstract

Advances in coronary artery revascularization have been accompanied by clinical trials evaluating these advances. Part I of this paper addressed historic trials related to coronary artery revascularization. This paper reviews the data supporting newer revascularization strategies for our patients, including drug-eluting stents and off-pump coronary artery bypass surgery. Benefits include reduced repeat revascularization in patients who undergo percutaneous treatments with drug-eluting stents, the durability of surgical arterial revascularization, and the importance of medical therapy as the mainstay of treatment.

摘要

冠状动脉血运重建技术的进步伴随着评估这些进展的临床试验。本文的第一部分论述了与冠状动脉血运重建相关的历史性试验。本文回顾了支持为我们的患者采用更新的血运重建策略的数据，包括药物洗脱支架和非体外循环冠状动脉旁路移植术。其益处包括接受药物洗脱支架经皮治疗的患者再次血运重建率降低、外科动脉血运重建的持久性以及药物治疗作为主要治疗手段的重要性。